Related references
Note: Only part of the references are listed.Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease
Eva Larouche-Lebel et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2021)
Gender-Related Differences in Heart Failure Biomarkers
German Cediel et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Retrospective evaluation of a dose-dependent effect of angiotensin-converting enzyme inhibitors on long-term outcome in dogs with cardiac disease
Jessica L. Ward et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2021)
Measurement of Equilibrium Angiotensin II in the Diagnosis of Primary Aldosteronism
Zeng Guo et al.
CLINICAL CHEMISTRY (2020)
Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism
Darcy Adin et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2020)
Effects of Ramipril on the Aldosterone/Renin Ratio and the Aldosterone/Angiotensin II Ratio in Patients With Primary Aldosteronism
Zeng Guo et al.
HYPERTENSION (2020)
The renin-angiotensin-aldosterone system and its suppression
Marisa K. Ames et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2019)
ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs
Bruce W. Keene et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2019)
Model-Based Reverse Translation Between Veterinary and Human Medicine: The One Health Initiative
Benjamin Schneider et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2018)
Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure
Vaibhav B. Patel et al.
CIRCULATION RESEARCH (2016)
Multiple comparison procedure and modeling: a versatile tool for evaluating dose-response relationships in veterinary pharmacology - a case study with furosemide
B. Bieth et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2016)
Modeling of Large Pharmacokinetic Data Using Nonlinear Mixed-Effects: A Paradigm Shift in Veterinary Pharmacology. A Case Study With Robenacoxib in Cats
L. Pelligand et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2016)
Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors
Milosz Regulski et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Pharmacokinetic/Pharmacodynamic Modeling of Renin-Angiotensin Aldosterone Biomarkers Following Angiotensin-Converting Enzyme (ACE) Inhibition Therapy with Benazepril in Dogs
Jonathan P. Mochel et al.
PHARMACEUTICAL RESEARCH (2015)
Influence of feeding schedules on the chronobiology of renin activity, urinary electrolytes and blood pressure in dogs
Jonathan P. Mochel et al.
CHRONOBIOLOGY INTERNATIONAL (2014)
New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) II: Albumin Suppresses Angiotensin Converting Enzyme (ACE) Activity in Human
Miklos Fagyas et al.
PLOS ONE (2014)
New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) I: Endogenous Angiotensin Converting Enzyme (ACE) Inhibition
Miklos Fagyas et al.
PLOS ONE (2014)
The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
Maricica Pacurari et al.
INTERNATIONAL JOURNAL OF INFLAMMATION (2014)
Chronobiology of the renin-angiotensin-aldosterone system in dogs: relation to blood pressure and renal physiology
Jonathan P. Mochel et al.
CHRONOBIOLOGY INTERNATIONAL (2013)
Beneficial Effects of the Activation of the Angiotensin-(1-7) Mas Receptor in a Murine Model of Adriamycin-Induced Nephropathy
Katia Daniela Silveira et al.
PLOS ONE (2013)
Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury
Yanfei Qi et al.
EXPERIMENTAL PHYSIOLOGY (2012)
Racial Differences in Blood Pressure Response toAngiotensin-Converting Enzyme Inhibitors in Children: A Meta-Analysis (vol 84, pg 315, 2008)
J. S. Li et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008
Kenneth Dickstein et al.
EUROPEAN HEART JOURNAL (2008)
Aminopeptidase A inhibitors as centrally acting antihypertensive agents
Laurence Bodineau et al.
HEART FAILURE REVIEWS (2008)
Racial differences in blood pressure response to angiotensin-converting enzyme inhibitors in children: A meta-analysis
J. S. Li et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Aminopeptidase N in arterial hypertension
Robert S. Danziger
HEART FAILURE REVIEWS (2008)
Prediction discrepancies for the evaluation of nonlinear mixed-effects models
France Mentre et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2006)
Pharmacokinetics and pharmacokinetic/pharmacodynamic relationships for angiotensin-converting enzyme inhibitors
PL Toutain et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2004)
Gender difference in the response to an angiotensinconverting enzyme inhibitor and a diuretic in hypertensive patients of African descent
C Falconnet et al.
JOURNAL OF HYPERTENSION (2004)
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
AV Chobanian et al.
HYPERTENSION (2003)
Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism
C Seifarth et al.
CLINICAL ENDOCRINOLOGY (2002)